{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:36:09Z","timestamp":1793262969263,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key R&D Program of China","award":["2018YFC1311500"],"award-info":[{"award-number":["2018YFC1311500"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670725"],"award-info":[{"award-number":["81670725"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970679"],"award-info":[{"award-number":["81970679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cyto.2020.154998","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T05:44:08Z","timestamp":1579499048000},"page":"154998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy"],"prefix":"10.1016","volume":"127","author":[{"given":"Mingqian","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.cyto.2020.154998_b0005","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2015.16535","article-title":"Management of graves disease: a review","volume":"314","author":"Burch","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.cyto.2020.154998_b0010","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cyto.2020.154998_b0015","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1600-6143.2004.00525.x","article-title":"High pretransplant serum levels of CXCL10\/IP-10 are related to increased risk of renal allograft failure","volume":"4","author":"Rotondi","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.cyto.2020.154998_b0020","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.4049\/jimmunol.158.9.4129","article-title":"Differential CC chemokine-induced enhancement of T helper cell cytokine production","volume":"158","author":"Karpus","year":"1997","journal-title":"J Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.154998_b0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2010","journal-title":"Clin Exp Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2020.154998_b0030","doi-asserted-by":"crossref","first-page":"R241","DOI":"10.1530\/EJE-14-0047","article-title":"Mechanisms in endocrinology: autoimmune thyroid disease: old and new players","volume":"170","author":"Effraimidis","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.cyto.2020.154998_b0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0035-1559631","article-title":"The role of iodine and selenium in autoimmune thyroiditis","volume":"47","author":"Duntas","year":"2015","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"10.1016\/j.cyto.2020.154998_b0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MED.0000000000000356","article-title":"Is selenium supplementation in autoimmune thyroid diseases justified?","volume":"24","author":"Winther","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diab. Obes."},{"issue":"2","key":"10.1016\/j.cyto.2020.154998_b0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/jc.2018-01713","article-title":"Role of selenium intake for risk and development of hyperthyroidism","volume":"104","author":"Wang","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.cyto.2020.154998_b0050","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cyto.2020.154998_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"European Group on Graves\u2019 Orbitopathy (EUGOGO), The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves","volume":"5","author":"Bartalena","year":"2016","journal-title":"Orbitopathy, Eur Thyroid J"},{"issue":"5","key":"10.1016\/j.cyto.2020.154998_b0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02137","article-title":"Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process","volume":"154","author":"Antonelli","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.cyto.2020.154998_b0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0019","volume":"156","author":"Inukai","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.cyto.2020.154998_b0070","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1189\/jlb.5A0717-302","article-title":"A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokines","volume":"102","author":"Zhao","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.cyto.2020.154998_b0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3945\/ajcn.2010.29642","article-title":"Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects","volume":"92","author":"Xia","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.cyto.2020.154998_b0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/bja\/aem091","article-title":"Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure","volume":"98","author":"Sakr","year":"2007","journal-title":"Br. J. Anaesth."},{"issue":"9","key":"10.1016\/j.cyto.2020.154998_b0085","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/00003246-199909000-00017","article-title":"Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome","volume":"27","author":"Angstwurm","year":"1999","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.cyto.2020.154998_b0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/thy.2016.0397","article-title":"Antioxidant actions of selenium in orbital fibroblasts: a basis for the effects of selenium in graves' orbitopathy","volume":"27","author":"Rotondo Dottore","year":"2017","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.cyto.2020.154998_b0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0167-5699(98)01294-8","article-title":"Selenium: an essential element for immune function","volume":"19","author":"Mckenzie","year":"1998","journal-title":"Immunol. Today"},{"issue":"5 Suppl 1","key":"10.1016\/j.cyto.2020.154998_b0100","doi-asserted-by":"crossref","first-page":"1457S","DOI":"10.1093\/jn\/133.5.1457S","article-title":"Selenium in the immune system","volume":"133","author":"Arthur","year":"2003","journal-title":"J. Nutr."},{"issue":"11","key":"10.1016\/j.cyto.2020.154998_b0105","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/mnfr.200700330","article-title":"The influence of selenium on immune responses","volume":"52","author":"Hoffmann","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"issue":"12","key":"10.1016\/j.cyto.2020.154998_b0110","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1210\/jc.2010-0191","article-title":"Selenium and the Thyroid: A Close-Knit Connection","volume":"95","author":"Duntas","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"20","key":"10.1016\/j.cyto.2020.154998_b0115","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"European Group on Graves, Selenium and the course of mild Graves' orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cyto.2020.154998_b0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2008.03219.x","article-title":"Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy","volume":"69","author":"Chen","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.cyto.2020.154998_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/JOE-11-0488","article-title":"beta (CCL2) and alpha (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-alpha agonists in Graves' ophthalmopathy","volume":"213","author":"Antonelli","year":"2012","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.cyto.2020.154998_b0130","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T Cell Subset in Graves\u00e2\u20ac\u2122 Ophthalmopathy","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:58:47Z","timestamp":1760907527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620300144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":26,"alternative-id":["S1043466620300144"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.154998","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.154998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154998"}}